Press "Enter" to skip to content

New patent expiration for Eisai Inc drug BANZEL

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Eisai Inc drug BANZEL

Annual Drug Patent Expirations for BANZEL
Annual Drug Patent Expirations for BANZEL

Banzel is a drug marketed by Eisai Inc and is included in two NDAs. It is available from one supplier. There are two patents protecting this drug and two Paragraph IV challenges.

BANZEL drug price trends.

Drug patent litigation for BANZEL.

The generic ingredient in BANZEL is rufinamide. One supplier is listed for this compound. Additional details are available on the rufinamide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Eisai Inc drug BANZEL
Do NOT follow this link or you will be banned from the site!